Developer docs
API playgroundTry for free, no card

Search company profiles

HeaIgen Scientific

Full company profile

uuid002b9fc

Namestring
HeaIgen Scientific
Legal namestring
Healgen
Websiteurl
healgen.us
Company typeenum
Private
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in-vitro diagnostics, rapid antigen testing, point-of-care diagnostics, drug screening kits, toxicology test kits
Industry3 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In-vitro diagnostics (IVD)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Diagnostic Product Sales
TypeHardware Sales
Description

Healgen generates revenue through the sale of rapid diagnostic test kits and devices, including FDA-cleared/authorized products for infectious diseases (COVID-19, Flu, Strep A), toxicology (fentanyl, multi-drug panels), and other clinical applications. Revenue is derived from one-time product transactions sold to healthcare providers, clinical laboratories, and consumers.

healgen.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Contact sales for product pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Healgen does not publicly list pricing for its diagnostic test products. Buyers must contact the company directly for quotes.

healgen.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Healgen AccuFluor
Description

Fentanyl FIA Test Kit product line

healgen.com
+3 more records
Core offering1 text field

Healgen Scientific develops, manufactures, and commercializes in-vitro diagnostic (IVD) rapid test systems spanning infectious disease (COVID-19, Flu A&B, Strep A), toxicology (multi-drug urine panels, fentanyl, xylazine), and consumer self-testing. The portfolio includes FDA 510(k)-cleared, De Novo-cleared, and CLIA-waived products sold to healthcare providers, clinical laboratories, toxicology screening programs, and individual consumers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Multi-panel drug detection including 18 substances with fentanyl sensitivity of 5 ng/mL calibrated to Norfentanyl
+1 more record
Product overview1 text field

Healgen is a leading global in-vitro diagnostics (IVD) developer and manufacturer offering a portfolio of rapid diagnostic tests. The company provides both CLIA-waived point-of-care tests and FDA-cleared over-the-counter products across several product families: the Accurate® line of multi-drug urine and oral fluid screening cups; the AccuFluor™ brand of fluorescent immunoassay tests; the Rapid Check® and Heal-Check lines for COVID-19 and respiratory disease testing; and specialty toxicology tests including fentanyl/xylazine and spiked drink detection. Healgen's products are designed for healthcare providers, workplaces, and consumers, addressing infectious diseases, toxicology/drug screening, and general health diagnostics.

Product and service11 records
1Healgen AccuFluor Fentanyl FIA Test Kit
CategoryToxicology / Drug Screening
Description

CLIA-waived rapid fentanyl screening test kit using fluorescent immunoassay (FIA) technology, designed for point-of-care fentanyl detection without requiring high-complexity laboratory infrastructure. Targeted at healthcare providers, harm reduction programs, and clinical settings responding to the opioid crisis.

2Healgen Accurate Oral Fluid Device
CategoryToxicology / Drug Screening
Description

FDA 510(k) cleared oral fluid drug testing device enabling non-invasive sample collection for workplace and clinical drug screening applications. Designed for employers, treatment programs, and clinical screening workflows.

3Accurate Multi-Drug Urine Drug Screen Cup
CategoryToxicology / Drug Screening
Description

FDA 510(k) cleared and CLIA-waived professional-use multi-drug urine screening cup detecting 18 substances including fentanyl at 5 ng/mL cutoff (calibrated to Norfentanyl) in a single device for point-of-care drug screening.

4Accurate Home Multi-Drug Urine Test Cup
CategoryToxicology / Drug Screening
Description

FDA 510(k) cleared and CLIA-waived over-the-counter 18-in-1 multi-drug urine test cup for home use, providing consumers with comprehensive drug screening including fentanyl detection.

5Healgen Rapid Check COVID-19/Flu A&B Antigen Test
CategoryInfectious Disease / Respiratory Diagnostics
Description

FDA De Novo cleared combination rapid antigen test detecting COVID-19 and Influenza A&B from a single sample, designed for over-the-counter consumer self-testing for respiratory disease differentiation.

6Healgen Rapid Check COVID-19/Flu A&B Antigen Test Professional
CategoryInfectious Disease / Respiratory Diagnostics
Description

FDA 510(k) cleared professional-use point-of-care version of the combined COVID-19/Flu A&B antigen test, intended for healthcare providers, clinics, urgent care centers, and physician offices.

7Healgen COVID-19/Flu A&B Ag Combo Rapid Test Cassette (Swab)
CategoryInfectious Disease / Respiratory Diagnostics
Description

Rapid test cassette for simultaneous detection of COVID-19 and Influenza A&B antigens from a single nasal swab sample, used for respiratory disease differentiation in clinical and point-of-care settings.

8Heal-Check Rapid COVID-19 Antigen Self-Test
CategoryInfectious Disease / Respiratory Diagnostics
Description

FDA 510(k) cleared over-the-counter COVID-19 antigen self-test for at-home use, expanding consumer access to rapid COVID-19 screening without visiting a healthcare facility.

9Strep A Test
CategoryInfectious Disease / Respiratory Diagnostics
Description

Rapid diagnostic test for detection of Group A Streptococcus bacteria causing strep throat, used in physician offices, urgent care centers, and clinical settings.

10Fentanyl/Xylazine Residue Test
CategoryToxicology / Drug Screening
Description

Rapid dual-detection test for fentanyl and xylazine residues, addressing emerging drug threat concerns for harm reduction, first responders, and substance abuse programs.

11Spiked Drink Test
CategoryToxicology / Drug Screening
Description

Rapid consumer test designed to detect date rape drugs or spiked beverages, marketed for personal safety screening by individuals.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Access Bio (CareStart COVID-19 and combo tests) is a direct peer in rapid antigen infectious disease diagnostics, with comparable professional and OTC channel strategies globally.

TypeDirect peer
Description

ACON Labs (Flowflex COVID-19 test, Mission Urine Drug Test Cups) is a close direct competitor in rapid antigen diagnostics and multi-panel urine drug screens with similar OTC and professional positioning.

TypeDirect peer
Description

iHealth built a major position in OTC COVID-19 antigen self-tests and broader consumer diagnostics, competing head-to-head with Healgen's Heal-Check self-test and OTC drug screen offerings.

TypeBroad incumbent
Description

BD's Veritor rapid antigen system and broader diagnostics portfolio compete with Healgen in POC infectious disease testing, while BD's drug-screening offerings overlap with Healgen's toxicology line.

TypeDirect peer
Description

Premier Biotech focuses on urine drug screening cups and oral fluid tests with FDA 510(k) clearances, closely mirroring Healgen's Accurate line in workplace and clinical toxicology.

TypeDirect peer
Description

OraSure pioneered oral fluid drug testing (Intercept) and rapid infectious disease diagnostics, directly comparable to Healgen's Accurate Oral Fluid Device and POC infectious disease portfolio.

TypeBroad incumbent
Description

Roche offers rapid antigen tests (SARS-CoV-2, Influenza) plus a broad diagnostics portfolio, competing with Healgen in POC respiratory testing and providing large-incumbent benchmark.

TypeDirect peer
Description

QuidelOrtho markets QuickVue and Sofia rapid antigen tests (COVID-19, Flu, Strep A) — directly overlapping with Healgen's Rapid Check and Strep A products at point-of-care and OTC channels.

TypeBroad incumbent
Description

Siemens Healthineers (CLINITEST rapid antigen, broad lab diagnostics) is a broad incumbent competing with Healgen across POC infectious disease testing and laboratory diagnostics.

10Abbott Diagnostics
TypeBroad incumbent
Description

Abbott's Diagnostics division (BinaxNOW, ID NOW, m-PIMA) competes directly in rapid antigen infectious disease testing and offers a broad IVD portfolio across hospital and POC settings, vastly larger than Healgen.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HeaIgen Scientific

In-vitro diagnostics (IVD)healgen.us

HeaIgen Scientific firmographics

Firmographics
Name
HeaIgen Scientific
Legal name
Healgen
Website
https://healgen.us
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

HeaIgen Scientific industry classification

Industry
Product category
In-vitro diagnostics (IVD)
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • In-vitro diagnostics
  • Rapid antigen testing
  • Point-of-care diagnostics
  • Drug screening kits
  • Toxicology test kits

Where HeaIgen Scientific is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HeaIgen Scientific business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Product Sales: Healgen generates revenue through the sale of rapid diagnostic test kits and devices, including FDA-cleared/authorized products for infectious diseases (COVID-19, Flu, Strep A), toxicology (fentanyl, multi-drug panels), and other clinical applications. Revenue is derived from one-time product transactions sold to healthcare providers, clinical laboratories, and consumers.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goContact sales for product pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

HeaIgen Scientific product offering

Product offering

Core offering

Healgen Scientific develops, manufactures, and commercializes in-vitro diagnostic (IVD) rapid test systems spanning infectious disease (COVID-19, Flu A&B, Strep A), toxicology (multi-drug urine panels, fentanyl, xylazine), and consumer self-testing. The portfolio includes FDA 510(k)-cleared, De Novo-cleared, and CLIA-waived products sold to healthcare providers, clinical laboratories, toxicology screening programs, and individual consumers.

Product overview

Healgen is a leading global in-vitro diagnostics (IVD) developer and manufacturer offering a portfolio of rapid diagnostic tests. The company provides both CLIA-waived point-of-care tests and FDA-cleared over-the-counter products across several product families: the Accurate® line of multi-drug urine and oral fluid screening cups; the AccuFluor™ brand of fluorescent immunoassay tests; the Rapid Check® and Heal-Check lines for COVID-19 and respiratory disease testing; and specialty toxicology tests including fentanyl/xylazine and spiked drink detection. Healgen's products are designed for healthcare providers, workplaces, and consumers, addressing infectious diseases, toxicology/drug screening, and general health diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

  • Healgen AccuFluor: Fentanyl FIA Test Kit product line
  • Rapid Check
  • Accurate
  • Heal-Check

Products and services

  • Healgen AccuFluor Fentanyl FIA Test Kit CLIA-waived rapid fentanyl screening test kit using fluorescent immunoassay (FIA) technology, designed for point-of-care fentanyl detection without requiring high-complexity laboratory infrastructure. Targeted at healthcare providers, harm reduction programs, and clinical settings responding to the opioid crisis.
  • Healgen Accurate Oral Fluid Device FDA 510(k) cleared oral fluid drug testing device enabling non-invasive sample collection for workplace and clinical drug screening applications. Designed for employers, treatment programs, and clinical screening workflows.
  • Accurate Multi-Drug Urine Drug Screen Cup FDA 510(k) cleared and CLIA-waived professional-use multi-drug urine screening cup detecting 18 substances including fentanyl at 5 ng/mL cutoff (calibrated to Norfentanyl) in a single device for point-of-care drug screening.
  • Accurate Home Multi-Drug Urine Test Cup FDA 510(k) cleared and CLIA-waived over-the-counter 18-in-1 multi-drug urine test cup for home use, providing consumers with comprehensive drug screening including fentanyl detection.
  • Healgen Rapid Check COVID-19/Flu A&B Antigen Test FDA De Novo cleared combination rapid antigen test detecting COVID-19 and Influenza A&B from a single sample, designed for over-the-counter consumer self-testing for respiratory disease differentiation.
  • Healgen Rapid Check COVID-19/Flu A&B Antigen Test Professional FDA 510(k) cleared professional-use point-of-care version of the combined COVID-19/Flu A&B antigen test, intended for healthcare providers, clinics, urgent care centers, and physician offices.
  • Healgen COVID-19/Flu A&B Ag Combo Rapid Test Cassette (Swab) Rapid test cassette for simultaneous detection of COVID-19 and Influenza A&B antigens from a single nasal swab sample, used for respiratory disease differentiation in clinical and point-of-care settings.
  • Heal-Check Rapid COVID-19 Antigen Self-Test FDA 510(k) cleared over-the-counter COVID-19 antigen self-test for at-home use, expanding consumer access to rapid COVID-19 screening without visiting a healthcare facility.
  • Strep A Test Rapid diagnostic test for detection of Group A Streptococcus bacteria causing strep throat, used in physician offices, urgent care centers, and clinical settings.
  • Fentanyl/Xylazine Residue Test Rapid dual-detection test for fentanyl and xylazine residues, addressing emerging drug threat concerns for harm reduction, first responders, and substance abuse programs.
  • Spiked Drink Test Rapid consumer test designed to detect date rape drugs or spiked beverages, marketed for personal safety screening by individuals.

Quantifiable outcome

  • Multi-panel drug detection including 18 substances with fentanyl sensitivity of 5 ng/mL calibrated to Norfentanyl
  • +1 more outcomes

Companies that use HeaIgen Scientific

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

HeaIgen Scientific technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

HeaIgen Scientific partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

HeaIgen Scientific competitors and assessment

Company assessment

Direct peers

  • Access Bio: Access Bio (CareStart COVID-19 and combo tests) is a direct peer in rapid antigen infectious disease diagnostics, with comparable professional and OTC channel strategies globally.
  • ACON Laboratories: ACON Labs (Flowflex COVID-19 test, Mission Urine Drug Test Cups) is a close direct competitor in rapid antigen diagnostics and multi-panel urine drug screens with similar OTC and professional positioning.
  • iHealth Labs: iHealth built a major position in OTC COVID-19 antigen self-tests and broader consumer diagnostics, competing head-to-head with Healgen's Heal-Check self-test and OTC drug screen offerings.
  • Premier Biotech: Premier Biotech focuses on urine drug screening cups and oral fluid tests with FDA 510(k) clearances, closely mirroring Healgen's Accurate line in workplace and clinical toxicology.
  • OraSure Technologies: OraSure pioneered oral fluid drug testing (Intercept) and rapid infectious disease diagnostics, directly comparable to Healgen's Accurate Oral Fluid Device and POC infectious disease portfolio.
  • QuidelOrtho: QuidelOrtho markets QuickVue and Sofia rapid antigen tests (COVID-19, Flu, Strep A) — directly overlapping with Healgen's Rapid Check and Strep A products at point-of-care and OTC channels.

Broad incumbents

  • Becton Dickinson (BD): BD's Veritor rapid antigen system and broader diagnostics portfolio compete with Healgen in POC infectious disease testing, while BD's drug-screening offerings overlap with Healgen's toxicology line.
  • Roche Diagnostics: Roche offers rapid antigen tests (SARS-CoV-2, Influenza) plus a broad diagnostics portfolio, competing with Healgen in POC respiratory testing and providing large-incumbent benchmark.
  • Siemens Healthineers: Siemens Healthineers (CLINITEST rapid antigen, broad lab diagnostics) is a broad incumbent competing with Healgen across POC infectious disease testing and laboratory diagnostics.
  • Abbott Diagnostics: Abbott's Diagnostics division (BinaxNOW, ID NOW, m-PIMA) competes directly in rapid antigen infectious disease testing and offers a broad IVD portfolio across hospital and POC settings, vastly larger than Healgen.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

HeaIgen Scientific social profiles

Digital presence

HeaIgen Scientific compliance and trust

Trust signal

Compliance2 records

HeaIgen Scientific financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HeaIgen Scientific leadership team

Management profile

Number of profiles

Profiles1 record

HeaIgen Scientific funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HeaIgen Scientific M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeaIgen Scientific

What does HeaIgen Scientific do?

Healgen Scientific develops, manufactures, and commercializes in-vitro diagnostic (IVD) rapid test systems spanning infectious disease (COVID-19, Flu A&B, Strep A), toxicology (multi-drug urine panels, fentanyl, xylazine), and consumer self-testing. The portfolio includes FDA 510(k)-cleared, De Novo-cleared, and CLIA-waived products sold to healthcare providers, clinical laboratories, toxicology screening programs, and individual consumers.

Is HeaIgen Scientific a public or private company?

HeaIgen Scientific is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was HeaIgen Scientific founded?

HeaIgen Scientific was founded in 2007. It employs 51 to 100 people.

Where is HeaIgen Scientific based?

HeaIgen Scientific is headquartered in Houston, United States, in the North America region.

How does HeaIgen Scientific make money?

One revenue line is on record: diagnostic Product Sales.

Who are HeaIgen Scientific's main competitors?

Direct peers on record are Access Bio, ACON Laboratories, iHealth Labs, Premier Biotech, OraSure Technologies and QuidelOrtho. Broad incumbents are Becton Dickinson (BD), Roche Diagnostics, Siemens Healthineers and Abbott Diagnostics.

Does HeaIgen Scientific have an API?

No public API is recorded for HeaIgen Scientific.

What industry is HeaIgen Scientific in?

HeaIgen Scientific's product category is In-vitro diagnostics (IVD). Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals